• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耳念珠菌,一种新兴的病原体——微生态系统生存的挑战。

Candida auris, an emerging pathogen - Challenge in the survival of microprimies.

机构信息

Department of Neonatology, Sri Ramachandra Institute of Higher Education & Research, Porur, Chennai, India.

Department of Microbiology, Sri Ramachandra Institute of Higher Education & Research, Porur, Chennai, India.

出版信息

Indian J Med Microbiol. 2021 Jul;39(3):367-369. doi: 10.1016/j.ijmmb.2021.03.025. Epub 2021 Apr 24.

DOI:10.1016/j.ijmmb.2021.03.025
PMID:33906749
Abstract

Clinical profile of extreme preterm neonates and more so, of microprimies with birth weight < 800 g is not studied till now. Our article elaborates the profile of 5 microprimies with C.auris sepsis and review of literature. The mean gestational age and birth weight were 26 weeks ± 5 days and 709 ± 64 g respectively. Mortality was 80%. The organism was susceptible to micafungin, voriconazole but was resistant to fluconazole and amphotericin. Among the 5 babies, one had organ involvement in the form of cardiac vegetation. Early identification and optimal choice of drug are crucial for better survival in C.auris sepsis.

摘要

目前尚未对极低出生体重儿,尤其是出生体重<800g 的极早产儿的临床特征进行研究。我们的文章阐述了 5 例患有耳念珠菌血症的极早产儿的临床特征,并对文献进行了回顾。平均胎龄和出生体重分别为 26 周±5 天和 709±64g。死亡率为 80%。该生物体对米卡芬净、伏立康唑敏感,但对氟康唑和两性霉素 B 耐药。在这 5 名婴儿中,有 1 名出现了心脏赘生物的器官受累。在耳念珠菌血症中,早期识别和选择最佳药物对提高生存率至关重要。

相似文献

1
Candida auris, an emerging pathogen - Challenge in the survival of microprimies.耳念珠菌,一种新兴的病原体——微生态系统生存的挑战。
Indian J Med Microbiol. 2021 Jul;39(3):367-369. doi: 10.1016/j.ijmmb.2021.03.025. Epub 2021 Apr 24.
2
Assessment of the and Antifungal Activity of NSC319726 against Candida auris.评估 NSC319726 对耳念珠菌的 和 抗真菌活性。
Microbiol Spectr. 2021 Dec 22;9(3):e0139521. doi: 10.1128/Spectrum.01395-21. Epub 2021 Nov 3.
3
Neonatal Candida auris infection: Management and prevention strategies - A single centre experience.新生儿耳念珠菌感染:管理与预防策略——单中心经验
J Paediatr Child Health. 2020 Oct;56(10):1565-1569. doi: 10.1111/jpc.15019. Epub 2020 Jul 16.
4
Evaluation of Antifungal Drug Combinations against Multidrug-Resistant Candida auris Isolates from New York Outbreak.针对来自纽约疫情的多重耐药耳念珠菌分离株的抗真菌药物联合评估
Antimicrob Agents Chemother. 2020 Mar 24;64(4). doi: 10.1128/AAC.02195-19.
5
Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.在科威特的多家医院中发现的耳念珠菌及其对抗真菌药物的敏感性和耐药的分子基础。
Mycoses. 2020 Jan;63(1):104-112. doi: 10.1111/myc.13022. Epub 2019 Nov 3.
6
Dissemination of Candida auris to deep organs in neonatal murine invasive candidiasis.新生鼠侵袭性念珠菌病中念珠菌属向深部器官的播散。
Microb Pathog. 2021 Dec;161(Pt B):105285. doi: 10.1016/j.micpath.2021.105285. Epub 2021 Nov 10.
7
Induction of amphotericin B resistance in susceptible by extracellular vesicles.细胞外囊泡诱导敏感株产生两性霉素 B 耐药性。
Emerg Microbes Infect. 2022 Dec;11(1):1900-1909. doi: 10.1080/22221751.2022.2098058.
8
The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.新兴病原体耳念珠菌:生长表型、毒力因子、抗真菌药物活性以及新型葡聚糖合成抑制剂SCY-078对生长形态和生物膜形成的影响
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02396-16. Print 2017 May.
9
Candida auris in Iran: A cause for concern?伊朗的耳念珠菌:一个值得关注的问题?
J Infect Public Health. 2024 Feb;17(2):370-371. doi: 10.1016/j.jiph.2024.01.003. Epub 2024 Jan 6.
10
Activities of nine antifungal agents against Candida auris biofilms.九种抗真菌药物对耳念珠菌生物膜的活性。
Mycoses. 2021 Apr;64(4):381-384. doi: 10.1111/myc.13223. Epub 2020 Dec 13.

引用本文的文献

1
First report of sepsis in a preterm infant; A new fungal threat in neonatal care.早产儿败血症的首次报告;新生儿护理中的一种新的真菌威胁。
Curr Med Mycol. 2024 Feb 1;10. doi: 10.22034/cmm.2024.345248.1565. eCollection 2024.
2
Neonatal Sepsis: A Comprehensive Review.新生儿败血症:全面综述
Antibiotics (Basel). 2024 Dec 25;14(1):6. doi: 10.3390/antibiotics14010006.
3
Perspectives on the Use of Echinocandins in the Neonatal Intensive Care Unit.新生儿重症监护病房中棘白菌素类药物的应用前景
Antibiotics (Basel). 2024 Dec 12;13(12):1209. doi: 10.3390/antibiotics13121209.
4
The laboratory investigation, management, and infection prevention and control of : a narrative review to inform the 2024 national guidance update in England.实验室调查、管理以及感染预防和控制:一篇叙述性综述,旨在为 2024 年英格兰国家指南更新提供信息。
J Med Microbiol. 2024 May;73(5). doi: 10.1099/jmm.0.001820.
5
It's time to shed some light on the importance of fungi in neonatal intensive care units: what do we know about the neonatal mycobiome?是时候阐明真菌在新生儿重症监护病房中的重要性了:我们对新生儿微生物组了解多少?
Front Microbiol. 2024 Mar 19;15:1355418. doi: 10.3389/fmicb.2024.1355418. eCollection 2024.
6
Infection, a Rapidly Emerging Threat in the Neonatal Intensive Care Units: A Systematic Review.感染,新生儿重症监护病房中迅速出现的威胁:一项系统综述
J Clin Med. 2024 Mar 10;13(6):1586. doi: 10.3390/jcm13061586.
7
Candida auris as the Predominant Species Causing Invasive Candidiasis in Neonates and Children.耳念珠菌是新生儿和儿童侵袭性念珠菌病的主要致病菌种。
Indian J Pediatr. 2023 Sep;90(9):946. doi: 10.1007/s12098-023-04672-z. Epub 2023 May 31.
8
Plasma and Cerebrospinal Fluid Concentrations of Micafungin Administered at High Doses in Critically Ill Infants with Systemic Candidiasis: A Pooled Analysis of Two Studies.高剂量米卡芬净在患有系统性念珠菌病的危重症婴儿中的血浆和脑脊液浓度:两项研究的汇总分析
Pharmaceuticals (Basel). 2023 Mar 22;16(3):472. doi: 10.3390/ph16030472.
9
Navigating the New Reality: A Review of the Epidemiological, Clinical, and Microbiological Characteristics of , with a Focus on Children.应对新现实:关于[具体疾病名称未给出]的流行病学、临床和微生物学特征的综述,重点关注儿童。
J Fungi (Basel). 2023 Jan 28;9(2):176. doi: 10.3390/jof9020176.
10
[Recent research on pharmacological prevention strategies for invasive fungal infection in preterm infants].[早产儿侵袭性真菌感染的药理学预防策略的最新研究]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Oct 15;24(10):1171-1177. doi: 10.7499/j.issn.1008-8830.2204158.